At the MedCity INVEST conference this week, a panel made up of two CEOs who took their companies public and a couple of venture investors talked about the advantages and drawbacks of going public compared with a strategic acquisition. They also drew attention to what’s changing in the marketplace.
Jan Garfinkle, Managing Director at Arboretum Ventures, moderated the panel, which included Annie Huntress Lamont, Managing Partner, Oak HC/FT; Michael DeMane, Chairman and CEO, Nevro Corp.; and Ray Huggenberger, CEO, Inogen Inc. all of whom discussed the dueling processes from a startup to having an exit.
Image: http://medcitynews.com
